Japan to mull use of hormone to halt metastases of lung cancer cells

Kenji Kangawa, head of Japan's National Cerebral and Cardiovascular Center, announces at a press conference in Osaka, western Japan, on Feb. 24, 2015, the launch of clinical studies involving hormone administration during lung cancer surgeries in a bid to prevent metastases of carcinogenic cells, billed as the world's first attempt of the kind. (Kyodo) ==Kyodo

• Product Code
• ILEA000064466

• Registered date
• 2015/2/24 20:13:08

• Credit
• Kyodo / Kyodo News Images

• Media source

• Media size
• 2806 × 3532 pixel

• Resolution
• 240 dpi

• Deployment size
• 957.81(KB)*

• Special instruction

*File size when opened in Photoshop, etc.